Muscle age and lifespan: beyond physiological strength-NHRI has discovered a direct link between skeletal muscle aging and mortality through thermogenic and metabolic abnormalities IBPR 2020-10-30 2020-11-05News & Events Using genetic modified mouse models, research at t… Continue reading
NHRI licenses DBPR216, an anti-cancer developmental drug candidate, to Taivex Therapeutics Corp IBPR 2019-04-17 2019-04-17News & Events The National Health Research Institutes (NHRI) and… Continue reading
Congratulation to Dr. Lun Kelvin Tsou, Associate Investigator of IBPR, on receiving the 14th Tien Te Lee Biomedical Young Scientists Award IBPR 2018-08-16 2018-08-31Awards & Honors Dr. Lun Kelvin Tsou, Associate Investigator of IBP… Continue reading
Congratulation to Dr. Hsing-Pang Hsieh, Investigator of IBPR, on receiving 2017 MOST Outstanding Research Award IBPR 2018-04-12 2018-04-13Awards & Honors Dr. Hsing-Pang Hsieh, Investigator of IBPR, was aw… Continue reading
Congratulation to Dr. Lun Kelvin Tsou, Associate Investigator of IBPR, on receiving 2018 NHRI Research Achievement Award IBPR 2018-03-10 2018-04-13Awards & Honors Dr. Lun Kelvin Tsou, Associate Investigator of IBP… Continue reading
National Health Research Institutes Announces FDA approval of Investigational New Drug (IND) Applications for Two Novel Small Molecules, DBPR211 and DBPR114 IBPR 2017-12-01 2018-01-16News & Events Institute of Biotechnology and Pharmaceutical Rese… Continue reading
Congratulations to the team that leads the project: “Pre-clinical investigation of the anti-cancer multi-kinase inhibitor：DBPR114”from IBPR for receiving the 26th Wang Ming-Ning Award by the Wang Ming-Ning memorial foundation. IBPR 2016-11-29 2017-07-07Awards & Honors Leading by Dr. Hsing-Pang Hsieh, the DBPR114 team … Continue reading
Congratulations to the team that leads the project: ‘’Developing of Novel Anti-cancer Drug Delivery System’’ from IBPR for receiving the 2016 Technology Achievement Award by the Ministry of Economic Affairs (MOEA). IBPR 2016-09-02 2016-10-18Awards & Honors To strengthen the integration of technical researc… Continue reading
Congratulations to the team that leads the project: ‘’The discovery and development of a novel small-molecule Hepatitis C virus inhibitor, DBPR110’’ from IBPR for receiving the 2016 Technology Transfer Award – Silver Medal Award by Taipei City Government. IBPR 2016-07-27 2016-10-21Awards & Honors The “Technology Transfer Award” is one… Continue reading
DBPR211, a novel small-molecule anti-type 2 diabetes drug candidate, was approved for Phase I clinical study by the US Food and Drug Administration (FDA) IBPR 2016-07-06 2016-07-06News & Events Institute of Biotechnology and Pharmaceutical Rese… Continue reading
